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Objectives. We evaluated a new techaique for delineation of the
vessel wall surface during intravascular oltrasound imaging using
echogenic contrast agents .
Background. Intravascular ultrasound ht used for detection of
complex vessel wall structures after catheter-based interventions ;
however, differentiation between the lumen and these wall struc-
tures can be difficult.
Afedtmh. In 12 anesthetized dogs, intraeoronary ultrasound
was performed during intracoronary bolus injection (3 and 6 ant) of
different contrast agents (hand-agitated saline solution, standard
iohexol, sonicated lohexol, hand-agitated inhexol, SURT 454, SHU
508) . Contrast intensity was quandfitd by videodenshometry, and
contrast homogeneity was assessed qualitatively (grade 0 to 3) .
Results. Peak contrast intensities for SHU 454 and SHU !W8
(mean [±SD] 48 t 9 and 36 ± 6 U, respectively) were higher
compared with standard, sonicated or agitated lohexol (16 ± 3,
28 ± 7 and 20 ± 3 U, respectively) or with a&'a7ated saline solution
(17 ± 4 U) ; intensities were higher for 6 ml compared with that for
3 ad . Contrast homogeneity was higher for SHU 508 (mean l±SDI
The morphology of the diseased arterial wall is an important
predictor of the natural history of the vessel (1) and the
response to interventions (2) . Recently, high frequency
intravascular ultrasound has been introduced as a new
technology that is able to demonstrate the vessel lumen and
wall boundaries in vivo (3) . Although intravascular ultra-
sound has been shown to be superior to angiography in the
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3.0 ± 0) and SHU 454 (23.05)compared with the other agents
(standard iohexol 1 .2 ± Q sonicated iohexol 2 .0 ± 0.5, agitated
iohexol 1 .8 ± U, agitated saline solution 1 .0 ± 0.4) . Exact
delineation of the vessel wall surface was possible in 100% of SHU
508 and in 88% of SHU 454 injections compared with 13% of
agitated iohexol and 8% of sonicated inhexol injections . Accurate
surface delineation was never achieved with standard iohexol or
agitated saline solution . Shadowing of parts of the vessel wall by
contrast material occurred at peak intensity of 75% of SHU 508
and 46% of SHU 454 injections but not with the ether agents . No
adverse physiologic reactions were noted, emcqv for transient
negative inotropic effects after 6 ml of SHU 508.
Conclusions. This preliminary study shows that delineation of
the vessel wall boundary using echogenic contrast agents during
hitravascular ultrasound is safe and feasible . Because of higher
contrast intensity and homogeneity, SHU 454 and SHU 508 are
superior to other agents .
(J Am Coll Cardiol 1994 ;23:981-7)
detection of dissections, tears and flaps (4), it may be difficult
to visualize these structures in all cases (5,6) even with this
technique. This is partly due to the fact that blood itself may
give a strong backscatter signal, especially in areas with low
blood flow (7) .
We evaluated a new technique with the potential to
improve the visualization of vessel wall surface using
echogenic contrast agents dwing intravascular ultrasound .
This approach is based on the assumption that the boundary
between blood and vessel wall can be enhanced by increas-
ing the blood backscatter with echogenic contrast agents .
Intracoronary application of echogenic contrast agents has
been widely used for evaluation of myocardial perfusion in
animals (8-12) and humans (13-20), including patients with
coronary artery disease (14-19). Except for transient nega-
tive inotropic effects (8-12), no serious side effects have
been observed .
Although contrast-enhanced intracoronary ultrasound
has been used in practice in some centers (21-23), a system-
atic analysis of this technique is lacking . This preliminary
report describes, for the first time, the in vivo use of
0735-1097194/$7 .0X0
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ultrasound contrast agents to improve delineation of the
vessel wall boundary during intracoronary high frequency
ultrasound imaging .
51edbods
tal model . Twelve mongrel dogs weighing 20
to 34 kg (mean [±SD] 27 ± 4 kg) were sedated with intra-
muscular injections of fentanyl and anesthetized intrave-
nously with 20 to 29 mg/kg of pentobarbital . Anesthesia was
maintained during the experiment with pentobarbital as
needed. The dogs were intubated with a cuffed endotracheal
tube and ventilated at 12 to 15 breaths/min with 500
ml/breath of room air using a Harvard Apparatus respirator .
A standard lead II electrocardiogram (ECO) using cutaneous
electrodes was displayed. A fluid-filled catheter was introduced
into the ascending aorta via cutdown of the right carotid artery,
and a Statham pressure transducer was used for pressure
measurement. Blood pressure and ECG were continuously
recorded at 25 mm/s before and for 2 min after each contrast
injection . An 8F sheath was introduced into the right femoral
artery with the Seldinger technique . By using fluoroscopic
guidance, an 8F "K-9" coronary guide catheter (Advanced
Cardiovascular Systems, Inc.) was placed into the left main
coronary artery and a 0 .014-in. guide wire was advanced into
the left circumflex coronary artery . The "dead space" volume
of this catheter was 3 ml . Intracoronary boluo injections of 6
and 3 ml of the contrast agents described later were performed
according to a set protocol . The guide catheter was flushed
initially with saline solution and was then injected rapidly with
a total of 9 ml of contrast agent. The dead space in the catheter
resulted in an intracoronary bolus of 6 ml . The volume of the
contrast agent remaining in the catheter (3 ml) was then given
as a second bolus by rapidly injecting 10 ml of saline solution
into the catheter. The studies were performed according to the
"Position of the American Heart Association of Research
Animal Use" adopted by the Association, on November 11,
I
Conhist agents. Seven different agents were selected for
intracoronary injection during intravascular ultrasound : 1)
Physiologic saline solution (control) . 2) Hand-agitated phys-
iologic saline solution : A 10-ml aliquot of saline solution was
agitated by pushing to and fro between two syringes con-
nected by a three-way stopcock until the solution turned
yish. Before injection, all visible air bubbles were care-
fully removed. 3) lohexol: This radiographic contrast agent
(Omnipaque) was prepared in 10-ml vials and was injected as
a standard solution . 4) Sonicated iohexol : Sonication was
performed as previously described by Keller et al . (24) . For
this purpose, 10 ml of iohexol contained in a 12-ml plastic
syringe was sonicated for 30 s at 20,000 MHz using a
comme.cially available sonication system (model W 185,
Heat Systems Ultrasonics) with a 112-in . probe . The tip of
the sonicator horn was placed below the surface of the
solution . During the sonication process, the syringe was
twice lowered to allow brief periods of surface agitation. The
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solution was administered within 3 min after preparation .
This technique of sonication has been shown to produce
microcavitations with a mean bubble size of approximately
6 Am (24) . 5) Hand-agitated iohexol: 10 ml of iohexol was
prepared by hand-agitation as described for saline solution .
6) SHU 454 : SHU 454 (Echovist) is a galactose ultrasound
contrast agent used for right heart contrast . It was prepared
by adding diluent to 4 g of SITU 454 to produce a suspension
of 300 mg microparticles/ml. The vial was shaken vigorously
until a homogeneous white suspension was obtained, which
was administered within 3 min. 7) SHU 508: SHU 508
(Levovist) is also a galactose contrast agent. As most of the
bubbles are able to pass the pulmonary circulation after
venous injection, this agent has been advocated for left heart
opacification . The solution was prepared by adding sterile
water to 5 g of SHU 508 to obtain a suspension of 200-mg
microparticles/ml. The vial was shaken vigorously until a
homogeneous white suspension was obtained, which was
administered within 3 min .
Intravascular ultrasound imaging. Intravascular ultra-
sound imaging was performed using a commercially avail-
able system (Cardiovascular Imaging Systems) with a 4 .3E
catheter and a center frequency of 30 MHz . The ultrasound
imaging catheter was introduced over the guide wire into the
midpart of the left circumflex artery to a segmental position
with a vessel diameter of 3 to 4 mm and without a side
branch . A transducer position was selected to obtain a stable
ultrasound image, and the time gain control settings were
adjusted to provide an optimal dynamic range . In the near
field, the settings were adjusted to deemphasize the blood
speckle ; in the far field, the time gain control was gradually
increased across the region of the vessel wall . The ultra-
sound images together with a lead 11 ECG were continuously
recorded on high quality 1/2-in . videotape before and for
2 min after the contrast injection .
Images were replayed on a video screen to identify the
frames selected for analysis ; these frames were digitized into
a 300 x 300-pixel matrix in 8 bits (Raster Ops) . A commer-
cially available image processing system (Adobe Photoshop)
was used for videodensitometry. A circular region of inter-
est, including approximately 1,500 pixels, was selected in the
vessel lumen (opposite to the catheter artifact). The gray
level for each pixel was expressed on a scale from 0 to 255,
with 255 representing the brightest value possible . The
intensity within the sample volume was expressed as the
mean gray level of all pixels . A time-intensity curve was
obtained by plotting these values frame by frame after
contrast injections . Measurements obtained from these
curves included contrast intensity at each end-systole, peak
end-diastolic intensity, time to peak end-systolic intensity
and total duration of the contrast effect . To describe homo-
geneity of the lumen contrast, the most optimal end-systolic
frame was selected, and a qualitative grading scale was
applied (0 = no bubbles visible, 1 = individual micro-
bubbles discernible, 2 = mixture of individual microbubbles
and homogeneous opacification, 3 = completely homoge-
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Figure 1 . Intravascular ultrasound images of the left circumflex
coronary artery during intracoronary contrast injection. Left, Phys-
iologic saline solution (control) . Right, Some contrast bubbles can
be seen after injection of 6 ml of hand-agitated saline solution .
neous intensity in all areas) . To describe the phenomenon of
shadowing, all areas of the vessel wall were carefully eval-
uated before contrast injection . Shadowing was considered
to be present when an arc >20 0 t f the vessel wall other than
the region of the catheter artifact was obscured during
contrast injection .
The cross-sectional lumen area of the vessel was calcu-
lated before and during 2 min after contrast infection. For
this pvpose, the interface between the vessel wall and the
!amen va as traced manually, and planimetry was performed
Lsing previously validated software . To study the echolucent
zone between the contrast-filled lumen and the echogenic
vessel wall, an ultrasound image with optimal contrast
homogenity and complete lumen opacification (grade 3) was
selected. In cases with incomplete or inhornogeneous con-
trast (grades 0 to 2), or both, delineation of the echolucent
zone was not performed . The interfaces between this zone,
the lumen and the vessel wall were traced manually, and the
mean thickness of this zone was calculated . For this pur-
pose, the lumen center was determined automatically, and
using this point as a reference, the mean thickness of the
Figure 2 . Intravascular ultrasound images of the left circumflex
coronary artery during intracoronary contrast injection . Left, A
non-homogeneous lumen contrast is produced after injection of 6 ml
of sonicated iohexol. Right, Injection of 6 ml of sonicated iohexol
results in brighter lumen opacification (intensity 30 U) with moder-
ate homogeneity (grade 2) .
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Fig , °e 3 . Intravascular ultrasound images of the left circumflex
coronary artery during intracoronary contrast injection . L';A, Dur-
ing injection of 6 ml of SHU 508, complete and homogeneous
contrast opacification of the vessel lumen is seen (intensity 47 U)
. A
small zone between the contrast-filled lumen and the vessel wall can
be detected (arrows). Right, Same injection but at higher contrast
intensity (59 U) . The contras, material produces shadowing of parts
of the vessel wall (arrows), which are located further away from the
transducer, whereas the vessel wall near the transducer is not
shadowed,
echolucent zone was calculated as an average from
equally spaced radial measurements .
Statistical analyses. Values are expressed as mean
value ± I SD . Changes in physiologic variables after intra-
coronary contrast injection are expressed as percent change
from baseline and calculated by paired t test. A p value of
<0.5 was considered significant .
suits
A total of 168 intracoronary contrast injections was
performed during intravascular ultrasound imaging . Before
contrast injection, echogenicity was lower in the vessel
lumen than in the vessel wall ; some lumen contrast is
produced by blood backscattcr . Injection of contrast mate-
rial produces opacification of the vessel lumen . As shown,
contrast intensity and homogeneity vary widely with the
type of agent used . During injection of agitated saline
solution, only some contrast bubbles can be seen (Fig . 1) .
Injection of sonicated iohexol or SHU 454 results in brighter
lumen opacification (Fig . 2). Figure'; shows an ultrasound
image wwwith complete and homogeneous opacification of the
vessel airmen after injection of SHU 508 . In this image, a
small zo :.e not filled with contrast medium can be seen
between ti ;e lumen and the vessel wall ; however, higher
contrast intensity during site same injection produces shad-
owing of some parts of the vessel wall (Fig . 3) .
Quantitative contrast effects . An example of the time
curve of contrast intensity as calculated from frame by frame
videodensitometry is illustrated in Figure 4 . The wash-in and
wash-out phenomenon of the contrast as well as the systolic/
diastolic variance can be seen . The values for peak contrast
intensity, time to peak contrast effect and total time of
contrast effect are listed in Table 1 ; the corresponding time
III
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0
6L
2 4 6 8
;0
Time after Contrast Injection (teats)
Rpm 4. An example of the time contrast intensity curve after
intracoronary injection of 3 ml of SHU 508 . Contrast intensity is
calcula ;,:d using frame by frame videorlensitometry
. Peak contrast
intensity occurs 6 beats after injection
. Note also the systolic/
diastolic variance in contrast intensity .
intensity curves are ated in Figures 4 and 5. SHU 454
and SHU 508 showed the highest intensity values, whereas
agitated saline solution and nonagitated iohexol showed the
lowest values. Contrast intensity of all agents was lower
during end-diastole than end-systole and lower with 3 ml
compared with 6 mll of bolus injection (Fig . 6). Intensity
usually peaked at 4 to 6 beats, and the contrast disappeared
at 10 to 18 beats after injection .
dtadve contrast effects. Agitated saline solution and
nonagitated iohexol showed the lowest contrast homogene-
ity (Table 2) . Homogeneous and complete opacification of
the vessel lumen (grade 3) was observed in most SHIT 454
and in all SHU 508 injections . A homogeneous contrast was
Table 1 . Quantitative Contrast Effects During Intracoronary Ultrasound 1 , r, mying
Data are mean value ± I SD
.
obtained during 48 (29%) of 168 injections . Only during these
homogeneous injections could the vessel wall boundary be
exactly delineated and the thickness of the non-contrasted
zone between lumen and vessel wall be measured (Fig . 3) .
The mean thickness of this zone ranged between !50 and
220 Am (mean [:tSD] 172 ± 20 gm) . Shadowing of parts of
the vessel wall by contrast material was observed in 8 (89%)
of the 9 images with contrast intensity >50 U and in 21(60%®)
of the 35 images with intensity of 40 to 50 U ; these high
intensity values were achieved only by SHU 454 or SITU
508. Shadowing usually occurred at parts of the vessel wall
located farther away from the transducer and was rarely
observed in parts of the vessel wall located near the trans-
ducer (Fig . 3) .
Physiologic effects. Changes in heart rate, aortic blood
pressure and cross-sectional area of the vessel lumen after
contrast injection are listed in Table 3 . Significant changes
from baseline were observed only after 6-ml injection of
SHU 508; all other agents and doses produced no significant
changes. The changes from 6-ml injection of SHU 508 are
illustrated in Figure 7: A significant decrease from baseline
was noted for diastolic (20 to 90 s after injection) and systolic
blood pressure (20 to 60 s) and for cross-sectional lumen area
(20 to 60 s) . All changes were reversible within 2 min after
injection. ST--T wave changes in the FCC were detected
during injection of sonicated iohexol, SHU 454 and SHU 508
and occurred most frequently with SHU 508 (Table 3) .
Discussion
With the refinement of catheter-based intracoronary in-
terventions, there has been a perceived need for more
JACC Vol . 23, No . 4
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Peak End-Systolic
Contrast
(U)
Peak End-Diastolic
Contrast
(U)
Time to Peak
Contrast
(beats)
Total Time of
Contrast
(beats)
Agitated saline solution
6ml
16.5 ± 3 .6 13.2±3 .3 6.1±1.0 B3 ± 1 .2
3 ml
12 .7 ± 2 .7 10.3±2 .7 4.8±0.4 W3 ± Ll
1ohCXQ1
6 ml 163 ± 3 .0 3.6±2.2 5.7±0.8 13.8±0
.9
3 ml 12 .7 ± 1 .6 10.9±1 .6
51 ± 14 11.5±1.3
Sonicated iohexol
6 ml 28.4 ± 7.4 23.6±6.8 5.8±C .7 94.8±1.7
3 ml No ± 51 RA ± 41 5.0±0.6 12.5±1.3
Agitated iohexol
6 ml 20.3 ± 2.6
16.8±2.8
53 ± 15 14. 4± 1 .6
3 ml BA ± 13 12.9±2.9 5.0±0.9 121 ± 1 .3
SHU 454
6m1
111 ± 5.8 28.9±5.5 6.6±1 .1 M1 ± 1 .5
3 ml
27.6 ± 5.9 22.4±4.6 5.5±0.5 13.1±1 .4
SHU 508
6ml 43 ± TO 38.7±6.5 6.3±0.5
16A ± 19
3 ml
36.9 ± 5.2 29.0±4.6 5.1±0.3 13.8±0 .9
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Figure 5 . End-systolic lumen contrast intensity after intracoronary
injection of 6 nil of contrast agent .
sophisticated techniques to visualize vessel lumen size and
plaque morphology . High frequency intravascular ultra-
sound has been introduced as a new technique that has the
advantage over angiography of providing tomographic,
cross-sectional views of the vessel lumen and vessel wall (3) .
Contrast enhancement during intravascular ultrasound is a
new technique based on the assumption that blood-perfused
parts of the lumen can be better differentiated from vessel
wall structures by increasing blood backscatter with
echogenic contrast agents . In the present study, the quanti-
tative and qualitative pattern of different contrast agents
during intracoronary ultrasound and their physiologic effects
are described in a dog model . The data demonstrate that
contrast enhancement is safe and feasible and that it has the
potential to improve visualization of the vessel wall boundary.
Pattern ofintracoronary contrast. Intracoronary contrast
injection provided short, dose-dependent lumen opacifica-
tion with a wash-in and wash-out phase. The contrast
showed a pulsatile pattern with lower intensities at end-
diastole compared with end-systole . This might be explained
by the increase in blood flow at this time, which has also
been shown to be associated with a lower blood backscatter
intensity (7) . The maximal lumen contrast intensity achieved
was different with the various agents . Maximal contrast
intensity from sonicated or agitated iohexol ranged between
20 and 30 U, whereas SHU 454 and SHU 508 provided the
highest intensity levels (30 to 60
-0). however, it is important
to remember that the contrast intensity also depends on the
baseline gain settings . In the present study, the near field
gain settings were adjusted to deemphasize the blood
speckle .
The major trade-off for more intense lumen opacification
is the problem of shadowing by contrast material . Shadow-
ing was observed in this study only during high contrast
intensity levels produced by SHU 454 or SHU 508 . Although
the phenomenon of shadowing limits the use of high contrast
intensities, images during the wash-in or wash-out period of
the same injection can be analyzed accurately . Shadowing
was observed in those vessel wall areas located further away
HA U-SMANN ET AL
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Figure 6 . End-systolic lumen contrast intensity after intracoronary
injection of 3 ml of contrast agent .
horn the transducer, indicating that the amount of contrast
material between the transducer and the vessel wall might
play a role . In vessel wall areas located near the transducer,
shadowing was not observed even with higher contrast
intensity levels . Therefore, in vessels narrowed by athero-
sclerotic plaque the problem of shadowing may be less
relevant because the wall surface is located near the trans-
ducer .
Besides intensity, the contrast homogeneity is essential
for delineation of the vessel wall surface . Surface detection
of small, complex vessel wall structures requires homogenous
and fine (dustlike) contrast . SHU 454 and SHU 508 provided
the most homogeneous contrast, with SHU 508 providing the
most even, probably owing to the smaller, more uniform
bubbles size of SHU 508 compared with that of St-lU 454 .
Table 2. Qualitative Contrast Effects During Intracoronary
Ultrasound Imaging
Agitated saline solution
6 ml 1 .0 ± 0 .4 0 0
3 ml 1 .1 ± 0 .3 0 0
lohexol
6 m! 1 .2 ± 0 .4 0 0
3 all 1 .1 ± 0 .3 0 0
Sonicated iohexol
6 ml 2.0±0 .5 2(17%) 0
3 ml 1.8±0.6 0 0
Agitated iohexol
6 ml 1 .8 ± 0 .6 1 (8%) 0
3 ml 1 .7 ± 0.5
2 (17%) 0
SITU 454
6 ml 2.7 ± 0 .5 11 (2%) 6 (50%)
3 ml
2.2 ± 0 .5 10(83%)
5 (42%)
SHU 508
6 ml
3.0 t 0
12 (100%) 10(83%)
3 ml 3.0 ± 0
12 (1 00 17o)
8 (67%)
Vessel
Contrast Wall Shadowing by
Hoinegenzity Delineation Contrast
(grade 1-3) Possible Material
(mean ± SD) (no.) (no .)
986
Exact delineation of vessel wall surface with other agents was
possible only in a few cases
. In images with homogeneous
opacification of the entire vessel lumen, a small zone not filled
with contrast was observed between the lumen and the vessel
wall. This zone probably represents the hypoechoic media.
which is not visualized in truly normal arteries using conven-
tional intravascular ultrasound imaging (25) .
Safety of intracorionary contrast application. Intracoro-
nary injections of echogenic contrast agents have been
performed safely in animals (8-12) and humans (13-20)
. The
circulatory effects awre comparable with those during conven-
tional contrast coronary angiography (13) and may consist of
transient negative inotropic effects with decrease in systemic
blood pressure (8-12), dPldt (8-10), left ventricular wall
7. Physiologic changes after intracoronary injection of 6 ml
of SHU 5013. Values are expressed as mean percent of baseline
values. *Significantly different compared with baseline values .
HAUSMANN ET AL
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Table 3 . Physiologic Changes During Intracoronary Contrast Ultrasound Imaging
Baseline
	
10 20 30 60 90
Time after Contrast injection teed
No. With ST-T
Wave Changes
"'Significant difference from baseline values
. Data are mean value ± SD . BP = blood pressure ; CSA = cross-sectional
area of coronary lumen .
Systolic DIP
0~ Diastolic 813
Lumen Area
0/12
0112
0/12
M2
0112
W12
Y12
3112
10112
M2
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motion disturbances (9,11) and transient bradycardia (13) ;
these effects are immediately reversible without persisting
problems
. The volume of the agents rather than the presence
of microbubbles seems to be the major detertninant of these
changes. Because nonionic agents ane known to produce less
hemodynamic disturbances, we used iohexol, which caused
no significant hemodynamic effects even after hand-agitation
or sonication. As ultrasound agents based on physiologic
agents (10) might also cause less physiologic changes, we
used two new galactose-based ultrasound agents (SHU 454,
SHU 508). Both agents were safe and caused no persisting
hemodynamic effects, except transient negative inotropic
effects after injection of a high dose (6 ml) SHU 508 . These
changes were accompanied by ST-T wave changes and a
decrease in coronary lumen area that may be explained by a
higher bubble density in the SHU 508 suspension .
Opthnal contrast agent for intravascular ultrasound imag-
ing. The optimal contrast agent for intravascular ultrasound
should provide bright and homogeneous (dustlike) opacifi-
cation of the entire vessel lumen ; on the other hand, contrast
shadowing of the vessel wall should be minimal. In images
with high contrast intensity, the echogenicity of the lumen
may approach that of the vessel wall ; this makes discrimi-
nation between lumen and wall more difficult. However, in
the clinical setting the contrast images are usually compared
with the baseline recordings, and higher contrast intensity
levels are often preferred . Neither agitated saline solution
nor nonagitated iohexol produce enough contrast intensity
or adequate homogeneity to fulfill these requirements . Al-
Percent Change From Baseline
Heart Rate Systolic BP Diastolic BP
CSA
Saline solution
6m1
-l
.0±5.8 +1.716.8
+0.8_ 5 .2 +2.2 ± 1 .5
3al
-0
.715.6
-0
.214.3 +2.0±5.3 0±3 .3
Agitated saline solution
6 ra1
-1
.01 9.4 014.0
-1
.8±± 10 .3 +1.7±2.3
3 ml
+0 .3 1 6.0 +1.414.8
+1.0±6.1 +2.5$2.6
lohexol
6 ml
-0
.4±8.7
-3
.3±6.5
-0
.5±5.4 At t 13
3 ml
+1.7±5.7
-1
.7±4 .8
-2
.3±4.8
-1
.4±3.0
Sonicated iohexol
t `ml +2.1±6.2
+0.8±4 .9
-1
.0±5.9
-0
.1±5.4
3 ml
+0.1±6.4 +1 .5±4.9
-3,1±7
.l QQ ± 3 .3
Agitated iohexol
6 ml +0.5±6.1
+0.6±3 .6 +1.1±5.9
+2.3±5.4
3 aml +3.1 ± 61
-11 ± 5
.3
-,7
.5±°8 .3 1A ± 6A
SHU 454
6m1 +1.1±9.5
--1
.5±5 .5 +1.5±8 .1 Of ± 31
3 all
-0
.1±6.9 0±4.8 +1.2±6.9 +2.4±2.7
SHU 508
6 ml
-3
.3±7.2
-9
.0±8.6"
-13
.4* V
-4
.6±3.2
3 in]
-0
.2±6.3 +0.1±6.0
-1
.7±7.7
-1
.7±4.3
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though sonicated iohexol provides more intense contrast, it
also lacks homogenous opacification of the entire lumen .
SHIJ 454 and 508 give bright intraluminal contrast and
homogeneous opacification in nearly all cases, allowing
exact delineation of the vessel wall surface . However, some
ultrasound images might be disturbed by shadowing due to
high contrast intensity levels from these agents, and tran-
sient hemodynamic disturbances can occur at higher dos-
ages .
Even if an optimal contrast agent can be identified, two
general problems of contrast bolus injections remain . 1) Only
5 to 10 beats of adequate opacification are usually obtained ;
this time window does not allow movement of the ultrasound
catheter along a vessel segment to search for certain wall
structures. Whether repeat contrast injections or brief con-
trast infusions can solve this problem remains a speculation .
2) The injection has to be performed proximal to the ultra-
sound transducer so that the contrast material passes the
imaging plane. This creates logistic problems during imaging
of peripheral arteries when the catheter is passed in a direction
opposite to the blood flow, (e.g ., for imaging of iliac arteries) .
Potential applications of intravascular contrast ultrasound .
Correct detection of complex vessel wall structures resulting
from vessel stretching (dissection, tears, flaps, ;.claque rup-
ture) or tissue removal after catheter-based intracoronary
interventions is clinically important (2) . Contrast enhance
ment during intravascular ultrasound has the potential to
improve visualization of these structures by better delinea-
tion of their lumen surfaces . Another potential application
might be to facilitate delineation of hypoechoic vessel wall
structures such as in early lipid-rich atherosclerotic intimal
disease . Echogenicity of these structures can be too low to
be differentiated from the blood backscatter (26) .
Conclusions . In summary, this study has shown the fea-
sibility and safety of contrast-enhanced intracoronary ultra-
sound in a dog model
. Intracoronary ultrasound contrast
produces opacification of the perfused vessel parts ; contrast
intensity and homogeneity depend on the contrast agents
and dosages used . This new approach has the potential to
improve delineation of the boundary of vessel wall struc-
tures. In addition to this preliminary work, further studies
are required to investigate the use of this technique in
humans, particularly after intracoronary interventions .
We
.re grateful to James Stoughton for excellent technical assistance in the
animal laboratory .
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